ONCT — Oncternal Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Oncternal Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20.1	117	90.8	63.7	34.3
Net Total Receivables	—	—	—	0.178	0.632
Prepaid Expenses
Total Current Assets	20.8	118	92.9	67.3	36.1
Net Property, Plant And Equipment	0.19	0.04	0.075	0.087	0.258
Other Long Term Assets
Total Assets	21.7	119	93.6	68.7	36.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.34	5.86	5.46	7.68	5.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.43	5.86	5.46	7.68	6.68
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.3	113	88.1	61	30.1
Total Liabilities & Shareholders' Equity	21.7	119	93.6	68.7	36.7
Total Common Shares Outstanding